![Erythego Gel,Brimonidine (5mg) 0.33%, Non prescription, Packaging Size: 15 ml at Rs 400/piece in Nagpur Erythego Gel,Brimonidine (5mg) 0.33%, Non prescription, Packaging Size: 15 ml at Rs 400/piece in Nagpur](http://5.imimg.com/data5/SELLER/Default/2023/4/301947224/OT/OT/LA/73733626/whatsapp-image-2023-04-04-at-20-16-31.jpeg)
Erythego Gel,Brimonidine (5mg) 0.33%, Non prescription, Packaging Size: 15 ml at Rs 400/piece in Nagpur
![These highlights do not include all the information needed to use MIRVASO® safely and effectively. See full prescribing information for MIRVASO.MIRVASO (brimonidine) topical gel Initial U.S. Approval: 1996 These highlights do not include all the information needed to use MIRVASO® safely and effectively. See full prescribing information for MIRVASO.MIRVASO (brimonidine) topical gel Initial U.S. Approval: 1996](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=P52848-3+Mirvaso+0.5+Gel+30g+Carton.jpg&id=677128)
These highlights do not include all the information needed to use MIRVASO® safely and effectively. See full prescribing information for MIRVASO.MIRVASO (brimonidine) topical gel Initial U.S. Approval: 1996
![Optimization and evaluation of encapsulated brimonidine tartrate-loaded nanoparticles incorporation in situ gel for efficient intraocular pressure reduction - Pharma Excipients Optimization and evaluation of encapsulated brimonidine tartrate-loaded nanoparticles incorporation in situ gel for efficient intraocular pressure reduction - Pharma Excipients](https://www.pharmaexcipients.com/wp-content/uploads/2020/05/Optimization-and-evaluation-of-encapsulated-brimonidine-tartrate-loaded-nanoparticles-incorporation-in-situ-gel-for-efficient-intraocular-pressure-reduction.png)
Optimization and evaluation of encapsulated brimonidine tartrate-loaded nanoparticles incorporation in situ gel for efficient intraocular pressure reduction - Pharma Excipients
![Efficacy and Safety of Once-Daily Topical Brimonidine Tartrate Gel 0.5% for the Treatment of Moderate to Severe Facial Erythema of Rosacea: Results of Two Randomized, Double-blind, and Vehicle-Controlled Pivotal Studies - JDDonline - Efficacy and Safety of Once-Daily Topical Brimonidine Tartrate Gel 0.5% for the Treatment of Moderate to Severe Facial Erythema of Rosacea: Results of Two Randomized, Double-blind, and Vehicle-Controlled Pivotal Studies - JDDonline -](http://dl.jddonline.com/articleimages/article_2166/table4.png)